|
Summary of
Contents (see Prospectus for Full Contents)
Executive
Summary
Autoimmune Therapeutics
Segment Dynamics
Evolving Models of Disease
and Human Health
Key Market Drivers and
Risk Factors
Patient Demographics and
Growth
Chronic Disease and
Self-administration
Managed Care and
Prescribing Trends
Factors Limiting Growth
Industry Alignment and
Competitive Landscape
Autoimmune Therapeutic
Market Assessments
Arthritis
Disease Forms and Immune
Mechanisms
Therapeutic Strategies
Disease Demographics and
Growth
Key Approved Therapies
Prescribing Trends
Development-stage
Candidate Assessment
Market Factors
Commercial Outlook and
Forecasts
Crohn’s Disease
Disease
Incidence and Demographics
The Limitations of
Screening and Diagnosis
Current Generation
Treatment Options
Therapies in Development
Market Factors
Commercial Outlook and
Forecasts
Diabetes
Restoring Islet
Cell Function
Therapies in Development
Commercial Outlook and
Forecasts
Lupus
The Ongoing Unmet Need
Difficult to Diagnose –
Difficult to Treat
Current Treatment Options
are Sparse
Moving Beyond
Corticosteroids
Pipeline Candidates – A
Ray of Hope
Market Factors
Commercial Outlook and
Forecasts
Multiple Sclerosis
Disease Mechanisms and
Therapeutic Strategies
The Market Opportunity
Competitive
Landscape
The Success of Interferons
The Versatility of
Antimetabolites
Approved Therapy
Assessment
Development-stage
Candidate Assessment
Market Factors
Commercial Outlook and
Forecasts
Psoriasis
Disease Mechanisms and
Therapeutic Targets
Therapeutic Options and
Expanded Indications
Prescribing Trends and
Drug Efficacy
Market Sector Factors and
Recent Developments
Development-stage
Candidate Assessment
Commercial Outlook and
Forecasts
Risk Factors
Clinical Trial Factors
Patient Enrollment and
Genotype Diversity
Establishing Realistic
Endpoints
Heterogeneous Disease
Targets
Product Issues
Competing with Generics
Packaging for Self-
Administration
Patient Acceptance Issues
Drug Safety Profiles
Side Effects and
Compliance
Autoimmune Therapeutics – Company Profile
|